Affiliation:
1. From the Lankenau Institute for Medical Research (M.H., J.B.D., G.C.P., L.D.L.-K.), Wynnewood Pa; and the Department of Pathology, Anatomy, and Cell Biology and Kimmel Cancer Center (G.C.P.), Thomas Jefferson University, Philadelphia Pa.
Abstract
Objective—
RhoB is a small GTPase localized at the plasma membrane and endosomes that participates in the regulation of endocytic trafficking of the epidermal growth factor (EGF) receptor and the nonreceptor kinases Src and Akt. This study was performed to determine whether RhoB plays a critical role in trafficking and signaling by the platelet-derived growth factor receptor-β (PDGFR-β) in vascular smooth muscle cells.
Methods and Results—
Cells derived from RhoB knockout mice failed to proliferate in response to PDGF, and downstream signaling was compromised as reflected by reduced phosphorylation of the effector kinases Akt and ERK1/2. In normal cells, PDGF stimulated trafficking of PDGFR-β into a perinuclear late endosomal compartment and triggered entry of Src, Akt, extracellular signal-regulated kinase (ERK) into the cell nucleus. In contrast, PDGF treatment of RhoB null cells resulted in neither PDGFR-β trafficking to late endosomes nor nuclear localization of Src, Akt, or ERK. In support of an essential function in these processes, restoring expression of RhoB in null cells rescued these defects and restored cell proliferation in response to PDGF.
Conclusion—
Our findings establish RhoB as a critical regulator of PDGFR-β trafficking and signaling in vascular smooth muscle cells.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献